Skip to site menu Skip to page content

Daily Newsletter

21 August 2023

Daily Newsletter

21 August 2023

Tasman Private Hospital project shelved over cost overruns

More than doubling of construction costs and interest rate hikes were cited as key reasons for the cancellation.

August 21 2023

The planned Tasman Private Hospital project in New Town, Hobart, Tasmania, has been called off due to 'cost pressures', reported ABC News.

This project, which was set to accommodate seven operating theatres, 26 overnight beds, and related medical services, received approval from Hobart City Council in 2021.

However, costs related to the project have spiralled from the original estimate of A$60m ($38.26m).

In a letter, developer Nexus Hospitals cited more than doubling of construction costs since 2021 and interest rate hikes over the last year as key reasons for abandoning the project.

The site prepared for the project will be sold off, with Nexus presently having no plans for another health facility.

The developer was quoted as saying: "As a result, any consideration to a future hospital development would require a comprehensive redesign on a different site."

Nexus also said that it assessed several options to resolve the project’s challenges and succeeded in addressing "some of the cost pressures", though these efforts proved inadequate in restoring the project’s “financial viability”.

The developer will now refocus on its other operations, including continuing operations of the Hobart Day Surgery.

Australian Medical Association vice-president Annette Barratt said: “While this wouldn't have a direct effect on the public sector, it would allow the public sector to have more beds for outsourcing.

“Already most of our public ophthalmic procedures are done in the south as outsourced so this would have given us additional beds and also additional beds with the capacity for overnight stays for frail people which is not something that's easily obtained in the current situation, so yes it would have been of benefit for that sector.”

Generative AI set to transform the medical devices industry

GlobalData estimates the total AI market will be worth $908.7 billion in 2030, with a 35% CAGR (2022-30). Generative AI can improve personalized healthcare by collecting data from patients via wearable devices. It can also enhance existing imaging techniques by generating high-quality images of organs using data from low-resolution images (such as ultrasounds). However, the collection and use of patient healthcare data and information through AI medical products could conflict with regulations around the globe.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close